Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2021

View Archived Issues

Insight into CD200R signaling has implications for treating systemic lupus erythematosus

New BBB-crossing FMR1-based AAVphp constructs for treatment of Fragile X syndrome

PDGFRA overexpression in prenatal OPCs results in CNS hypomyelination

New nanoformulation provides a promising candidate for long-acting dosing of tenofovir

CXCR4-CXCL12 signaling axis as therapeutic target for Lewy body dementia

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

TGF-beta receptor type-1 inhibitors discovered at Theravance Biopharma

Medshine Discovery presents new DNA-dependent protein kinase inhibitors

ADAMTS5 inhibitors patented by Shenzhen Salubris Pharmaceuticals

New ENPP1 inhibitors discovered at Betta Pharmaceuticals

JMV-7488, a new 68Ga-radiolabeled peptide analogue for cancer imaging

Novel anti-inflammatory agent significantly improves LPS-induced sepsis in vivo

99mTc-Labeled rituximab allows imaging of CD-20-expressing melanoma

Chemoattractant attachment boosts antibiotic efficacy

[64Cu]CuHTE1PA-9E7.4 use as a theranostic agent for multiple myeloma

Targeting IKK-beta in cardiac fibroblasts may protect against heart failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...